Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor

L J Hall1, C T Murphy, A Quinlan

  • 1Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland. Lindsay.Hall@uea.ac.uk

Mucosal Immunology
|January 24, 2013
PubMed

Insights

Natural killer (NK) cells regulate inflammation in inflammatory bowel disease. These cells dampen neutrophil-driven tissue injury and inflammation in dextran sodium sulfate-induced colitis via NKG2A-dependent mechanisms.

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • Natural killer (NK) cells are primarily known for tumor surveillance and infection defense.
  • Their role in chronic inflammatory disorders like inflammatory bowel disease (IBD) remains less understood.

Purpose of the Study:

  • To investigate the function of NK cells in dextran sodium sulfate (DSS)-induced colitis, a model for IBD.
  • To elucidate the mechanisms by which NK cells modulate inflammation and tissue damage in this model.

Main Methods:

  • Utilized a mouse model of DSS-induced colitis.
  • Depleted NK cells to assess their impact on disease severity.
  • Conducted in vitro and in vivo experiments to analyze neutrophil activation and NK cell interactions.
  • Investigated the role of the NKG2A receptor in NK cell-mediated regulation.

Main Results:

  • Depletion of NK cells exacerbated colitis, leading to increased colonic damage and leukocyte infiltration.
  • Mice lacking NK cells showed elevated neutrophil numbers and hyper-activation in the colon and mesenteric lymph nodes.
  • NK cells directly suppressed neutrophil pro-inflammatory functions, including reactive oxygen species and cytokine production.
  • This suppression was mediated by cell-to-cell contact involving the NKG2A receptor.

Conclusions:

  • NK cells play a crucial immunoregulatory role in attenuating DSS-induced colitis.
  • NK cells mitigate neutrophil-driven inflammation and tissue injury through NKG2A-dependent mechanisms.
  • These findings highlight a novel therapeutic target for managing inflammatory bowel disease.